Based in Heidelberg, we invest throughout Europe with the aim to build companies that create significant commercial opportunities based on new therapeutic treatment modalities and pharmaceuticals, next generation enabling technology platforms or innovations in the diagnostics and medical device area. Besides our investment activities, we offer consulting to life science companies with a focus on company building, M&A, corporate strategy as well as in- and out-licensing. Our team has a significant scientific and life science industry related network, a strong investment track record as well as experience in building successful companies, closing collaboration- and licensing agreements, M&A's and IPOs.
Looking for a particular EMBL Ventures employee's phone or email?
The EMBL Ventures annual revenue was $359.3 million in 2026.
The NAICS codes for EMBL Ventures are [541, 54, 5417].
The SIC codes for EMBL Ventures are [87, 873].